» Articles » PMID: 26747708

A Borrelia Burgdorferi Surface-Exposed Transmembrane Protein Lacking Detectable Immune Responses Supports Pathogen Persistence and Constitutes a Vaccine Target

Overview
Journal J Infect Dis
Date 2016 Jan 10
PMID 26747708
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Borrelia burgdorferi harbors a limited set of transmembrane surface proteins, most of which constitute key targets of humoral immune responses. Here we show that BB0405, a conserved membrane-spanning protein of unknown function, fails to evoke detectable antibody responses despite its extracellular exposure. bb0405 is a member of an operon and ubiquitously expressed throughout the rodent-tick infection cycle. The gene product serves an essential function in vivo, as bb0405-deletion mutants are unable to transmit from ticks and establish infection in mammalian hosts. Despite the lack of BB0405-specific immunoglobulin M or immunoglobulin G antibodies during natural infection, mice immunized with a recombinant version of the protein elicited high-titer and remarkably long-lasting antibody responses, conferring significant host protection against tick-borne infection. Taken together, these studies highlight the essential role of an apparently immune-invisible borrelial transmembrane protein in facilitating infection and its usefulness as a target of protective host immunity blocking the transmission of B. burgdorferi.

Citing Articles

Borrelial phosphomannose isomerase as a cell surface localized protein that retains enzymatic activity and promotes host-pathogen interaction.

Dutta S, Rana V, Backstedt B, Shakya A, Kitsou C, Yas O mBio. 2025; 16(3):e0360924.

PMID: 39932273 PMC: 11898738. DOI: 10.1128/mbio.03609-24.


Decoding trends in mRNA vaccine research: A comprehensive bibliometric study.

Zhang C, Wang Y, Peng J, Wen X, Zhang Y, Li K Hum Vaccin Immunother. 2024; 20(1):2355037.

PMID: 38813652 PMC: 11141478. DOI: 10.1080/21645515.2024.2355037.


Extensive diversity in RNA termination and regulation revealed by transcriptome mapping for the Lyme pathogen Borrelia burgdorferi.

Petroni E, Esnault C, Tetreault D, Dale R, Storz G, Adams P Nat Commun. 2023; 14(1):3931.

PMID: 37402717 PMC: 10319736. DOI: 10.1038/s41467-023-39576-1.


Extensive diversity in RNA termination and regulation revealed by transcriptome mapping for the Lyme pathogen .

Petroni E, Esnault C, Tetreault D, Dale R, Storz G, Adams P bioRxiv. 2023; .

PMID: 36712141 PMC: 9881889. DOI: 10.1101/2023.01.04.522626.


Visualization of the Dynamics of Invasion and Intravasation of the Bacterium That Causes Lyme Disease in a Tissue Engineered Dermal Microvessel Model.

Guo Z, Zhao N, Chung T, Singh A, Pandey I, Wang L Adv Sci (Weinh). 2022; 9(35):e2204395.

PMID: 36156464 PMC: 9762293. DOI: 10.1002/advs.202204395.


References
1.
Fraser C, Casjens S, Huang W, Sutton G, Clayton R, Lathigra R . Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature. 1997; 390(6660):580-6. DOI: 10.1038/37551. View

2.
Steere A, Sikand V, Meurice F, Parenti D, Fikrig E, Schoen R . Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med. 1998; 339(4):209-15. DOI: 10.1056/NEJM199807233390401. View

3.
Bunikis J, Barbour A . Access of antibody or trypsin to an integral outer membrane protein (P66) of Borrelia burgdorferi is hindered by Osp lipoproteins. Infect Immun. 1999; 67(6):2874-83. PMC: 96595. DOI: 10.1128/IAI.67.6.2874-2883.1999. View

4.
Rosa P, Tilly K, Stewart P . The burgeoning molecular genetics of the Lyme disease spirochaete. Nat Rev Microbiol. 2005; 3(2):129-43. DOI: 10.1038/nrmicro1086. View

5.
Brooks C, Vuppala S, Jett A, Akins D . Identification of Borrelia burgdorferi outer surface proteins. Infect Immun. 2005; 74(1):296-304. PMC: 1346608. DOI: 10.1128/IAI.74.1.296-304.2006. View